BridgeMD
Compares treatment options for Developmental Hip Dysplasia
Official title Pavlik Harness Treatment vs Monitoring for Treatment of Developmental Dysplasia of the Hip (DDH) in Babies Diagnosed With Graf Type 2 Hips
ClinicalTrials.gov ID: NCT07111858
What this study is testing
- What it's testing
- Developmental Dysplasia of the Hip (DDH) is thoroughly manageable if treated correctly. While the standard treatment is using a Pavlik harness, there is not enough research regarding those patients who have stable but immature Graf type 2b and 2c hips and whether a harness is needed.
- Time commitment: about 15 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 16
You may be able to join if
- Infants from birth to 16 weeks with Graf type 2b or 2c hip dysplasia on ultrasound
You likely can't join if
- associated neuromuscular, genetic or neurological condition which may complicate the course of treatment
- babies who have unstable hips on clinical examination
The study team makes the final eligibility decision.
Where it's taking place
- Royal Tunbridge Wells, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 15 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 0 weeks to 16 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Royal Tunbridge Wells, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.